Found 30 matching trials
Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC
PHASE2This is a Phase II, open label, randomized study of durvalumab in combinati...
Location
Huntsman Cancer Institute at University of Utah
Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal Cancer
PHASE3This is an open-label, multicenter, randomized study to be conducted in Chi...
Location
Sun Yat-Sen University Cancer Center
Anti Reflux Mucosal Ablation Therapy in PPI Dependent GERD
NAThis is a prospective, randomized, single-blinded, interventional, controll...
Location
II Medizinische Klinik am Klinikum rechts der Isar der Technischen Universität München
JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma
PHASE2This open-label, multicenter phase II study was designed to evaluate the sa...
Location
The First Affiliated Hospital of USTC
Antireflux Ablation of the Cardia Mucosa vs Placebo for the Treatment of Gastroesophageal Reflux Disease
NAThe ARMA technique improves GORD-related quality of life with a low proport...
Location
Hospital de San Agustín
Randomized Study With Midazolam for Sedation in Flexible Bronchoscopy
NAThe Flexible Bronchoscopy (FB) is a diagnostic and therapeutic procedure wh...
Location
Hospital Universaitario La Fe
ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease
NAPilot study of the possible clinical response to anti reflux mucosal ablati...
Location
Klinikum Garmisch-Partenkirchen
Anti-Reflux Mucosal Ablation(ARMA) and Anti-Reflux Mucosectomy(ARMS) in Gastroesophageal Reflux Disease
NAAccording to the current published data and treatment mechanism, ARMS may l...
Location
Multiple Locations
Pilot Study: Home Use of Wearable Grasping Neuroprosthesis in Vascular Hemiparesis
NAStroke is the leading cause of acquired motor disability in adults. Six mon...
Location
University Hospital Toulouse
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors
NAThis is a pilot study designed to evaluate the cutaneous effect of systemic...
Location
University of Arizona Cancer Center